Urologic Oncology: Seminars and Original Investigations
Volume 30, Issue 2 , Pages 150-154 , March 2012

111-In-capromab pendetide imaging using hybrid-γ camera-computer tomography technology is not reliable in detecting seminal vesicle invasion in patients with prostate cancer

  • Matvey Tsivian, M.D.

      Affiliations

    • Duke Prostate Center and Division of Urologic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-919-684-0787; fax: +1-919-684-5220
    • ,
  • Tiera Wright, DrPH

      Affiliations

    • Duke Prostate Center and Division of Urologic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    • ,
  • Marva Price, DrPH

      Affiliations

    • School of Nursing, Duke University Medical Center, Durham, NC 27710, USA
    • ,
  • Vladimir Mouraviev, M.D., Ph.D.

      Affiliations

    • Duke Prostate Center and Division of Urologic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    • ,
  • John F. Madden, M.D., Ph.D.

      Affiliations

    • Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    • ,
  • Masaki Kimura, M.D.

      Affiliations

    • Duke Prostate Center and Division of Urologic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    • ,
  • Terrence Wong, M.D., Ph.D.

      Affiliations

    • Department of Radiology/Nuclear Medicine, Duke University Medical Center, Durham, NC 27710, USA
    • ,
  • Thomas J. Polascik, M.D.

      Affiliations

    • Duke Prostate Center and Division of Urologic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA

Received 13 November 2009 ,Revised 3 December 2009 ,Accepted 4 December 2009.

References 

  1. Gallina A , Chun FK , Briganti A , et al.  Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy . Eur Urol . 2007;52:98–105
  2. Makarov DV , Trock BJ , Humphreys EB , et al.  Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005 . Urology . 2007;69:1095–1101
  3. Partin AW , Yoo J , Carter HB , et al.  The use of prostate specific antigen, clinical stage, and Gleason score to predict pathologic stage in men with localized prostate cancer . J Urol . 1993;150:110–114
  4. Chun FK , Graefen M , Zacharias M , et al.  Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer . World J Urol . 2006;24:273–280
  5. Zorn KC , Capitanio U , Jeldres C , et al.  Multi-institutional external validation of seminal vesicle invasion nomograms: Head-to-head comparison of Gallina nomogram vs. 2007 Partin tables . Int J Radiat Oncol Biol Phys . 2009;73:1461–1467
  6. Greene FLPD , Fleming ID , Fritz A , et al.  AJCC cancer staging manual . 6th ed.. Philadelphia: Springer; 2002;
  7. Koontz BF , Mouraviev V , Johnson JL , et al.  Use of local (111)In-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer . Int J Radiat Oncol Biol Phys . 2008;71:358–361
  8. D'Amico AV , Moul J , Carroll PR , et al.  Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era . J Clin Oncol . 2003;21:2163–2172
  9. Sodee DB , Sodee AE , Bakale G . Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer . Semin Nucl Med . 2007;37:17–28
  10. Wong TZ , Turkington TG , Polascik TJ , et al.  ProstaScint (capromab pendetide) imaging using hybrid-γ camera-CT technology . AJR Am J Roentgenol . 2005;184:676–680
  11. Lau HY , Kindrachuk G , Carter M , et al.  Surgical confirmation of ProstaScint abnormalities in two patients with high risk prostate cancer . Can J Urol . 2001;8:1199–1202
  12. Raj GV , Partin AW , Polascik TJ . Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy . Cancer . 2002;94:987–996
  13. Ponsky LE , Cherullo EE , Starkey R , et al.  Evaluation of preoperative ProstaScint scans in the prediction of nodal disease . Prostate Cancer Prostatic Dis . 2002;5:132–135
  14. Ellis RJ , Kim EY , Conant R , et al.  Radioimmunoguided imaging of prostate cancer foci with histopathological correlation . Int J Radiat Oncol Biol Phys . 2001;49:1281–1286
  15. Sodee DB , Malguria N , Faulhaber P , et al.  Multicenter ProstaScint imaging findings in 2,154 patients with prostate cancer (The ProstaScint Imaging Centers) . Urology . 2000;56:988–993
  16. Lange PH . ProstaScint scan for staging prostate cancer . Urology . 2001;57:402–406
  17. Kinoshita Y , Kuratsukuri K , Landas S , et al.  Expression of prostate-specific membrane antigen in normal and malignant human tissues . World J Surg . 2006;30:628–636
  18. Mannweiler S , Amersdorfer P , Trajanoski S , et al.  Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis . Pathol Oncol Res . 2009;15:167–172
  19. Seltzer MA , Barbaric Z , Belldegrun A , et al.  Comparison of helical computerized tomography, positron emission tomography, and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer . J Urol . 1999;162:1322–1328

PII: S1078-1439(09)00405-0

doi: 10.1016/j.urolonc.2009.12.005

Urologic Oncology: Seminars and Original Investigations
Volume 30, Issue 2 , Pages 150-154 , March 2012

Article Tools